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Abstract – Acute kidney injury (AKI) is a
common complication associated with
cardiac surgery. AKI is associated with
increased hospital costs, hospital length of
stay (LOS), and mortality risk. The current
diagnostic criteria rely on serum creatinine
measurements and urine output data.
Serum creatinine is not renal specific. It is
known that there are factors other than
renal injury that influence serum creatine
concentrations. Serum creatinine levels are
measured as concentrations which means
large changes in fluid balance may alter the
serum creatinine concentration. Urine
output is not a reliable measurement of
renal injury, either. During surgery it is
common to administer diuretics which
influence urine output independent of renal
damage. Neither of these measures are
prognostic, which precludes the prevention
of the injury. Thus, researchers are
investigating novel biomarkers that are
renal specific and can monitor AKI risk in
real time. Some researchers are focused on
identifying chemical biomarkers to
diagnose AKI more effectively. However,
their use is limited due to cost and time.
Preliminary studies have also shown that
urine oxygen concentration may be a
physiological biomarker that can be used to
monitor AKI risk in real time. Urine oxygen
concentration may reflect tissue oxygen
concentration in the medullary region of the
kidney. This measurement is affected by
oxygen exchange between urine and the
urinary tract tissue. The aim of this study
was to investigate the relationship between
urine flow rate and the performance of a
novel device to monitor AKI risk in real time.

The results from this study suggest that is
possible to monitor oxygen concentration
non-invasively and that as the urine flow
rate increases the performance of the
device improves.
INTRODUCTION AND BACKGROUND
Acute kidney injury (AKI) occurs in
approximately 30% off all patients who
undergo cardiac surgery.1 AKI is described by
an acute decrease in renal function and is
associated with decreased urine output and
excess metabolites in the urine. One study
found that mild to moderate AKI was
associated with increased hospital length of
stay (LOS), hospital associated costs, and risk
of death.2 Severe AKI, which requires renal
replacement therapy (RRT), is associated
with mortality rates as high as 50-90% and
an 8-fold increase in the risk of death.3,4 It is
important to accurately diagnose impending
AKI and further investigate therapies or
treatments to protect patients from
developing this condition.
The diagnostic definition of AKI has changed
over time as new standards and criteria have
been developed. The Acute Dialysis Quality
Initiative (ADQI) group was the first group to
develop a uniform diagnostic criterion,
which became known as the RIFLE criteria.
This standard uses a three tiered severity
system that is based on the subjects
glomerular filtration rate (GFR) or urine
output.5 In 2007 the Acute Kidney Injury
Network (AKIN) modified the RIFLE criteria
with the hope of creating a uniform standard
with higher sensitivity for detecting AKI. This
definition of AKI is based on an increase in
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serum
creatinine
concentration
or
6
decreased urine output. A study from
Engleberger et. al found that significantly
more patients were diagnosed with AKI
when using the AKIN criteria compared to
the RIFLE criteria.7 The most recent standard
has been set forth by Kidney Disease
Improving Global Outcomes (KDIGO) group
with the goal of creating a universal standard
that could be uniformly applied to future
research studies. This new standard is based
on the previous RIFLE and AKIN criteria and
uses serum creatinine concentrations or
urine output data to diagnose patients with
AKI.8 While increased serum creatinine
concentrations and decreased urine output
have been associated with impaired renal
function, these markers are not perfect
indicators of renal injury because they are
influenced by factors other than kidney
function, are only related to the function of
the kidney (rather than the injury or even the
cause of it), and are only diagnostic after the
injury has already occurred. This precludes
the prevention of the disease.
One study found that the half-life of creatine
dramatically increases when there is a 5 %
reduction in kidney function9. This means
that serum creatinine levels may not rise
until several days after the initial renal
injury. In fact, one paper states that serum
creatinine does not change until 48-72 hours
after the initial insult.10 This does not help
prevent or mitigate AKI, and shows that
serum creatinine concentrations can only be
used as a post-injury diagnostic tool.9 In
addition, because serum creatinine is
measured as a concentration it is affected by
changes in volume. This means that patients
who are given large amounts of fluid will
have
a
lower
serum
creatinine
concentration, independent of whether they
experienced renal injury. This may lead to
the underdiagnosing of kidney injury as the

rise in serum creatinine will be masked by
the dilutional effect of fluid administration.
It is also known that serum creatinine
concentrations are affected by certain drugs
that alter the concentration independent of
renal injury or damage.11 Another concern
with using serum creatinine as a measure of
renal injury is that the definitions for AKI
require a baseline measurement. If there is
not a baseline measurement it is often
estimated through various methods which
require assumptions about the patient’s
health and prior renal function.
The validity of urine output as a marker for
renal injury has also recently been
questioned. Some researchers argue that
the KDIGO urine output AKI definition has
not been validated, and that the definition is
too liberal. One study showed that those
patients who were under a threshold of 0.3
ml/kg/hr for 6 hours or longer had a higher
risk of death and need for dialysis.12 The
current criteria uses 0.5 ml/kg/hr as a
threshold. It is also important to consider
that urine output is affected by
administration of diuretics which are
commonly given during surgery. Like serum
creatinine measurements this may lead to
underdiagnosis of injury as the patient will
not meet the criteria for AKI, although injury
is present. For these reasons it is important
to identify other physiological biomarkers
that are renal specific, could be used to
identify renal injury, and monitor AKI risk in
real time.
Researchers have studied the role of
neutrophil gelatinase-associated lipocalin
(NGAL) as a potential biomarker for
diagnosing AKI. It has been reported that
following renal injury there is an increase in
uptake of NGAL, which gives researchers
hope that it can be used in place of the
conventional biomarkers currently used.13
However, other research has shown that the
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Figure 1 - An image of the device that was used to measure urine oxygen concentration and urine flow rate. The device was
placed between the end of the urinary catheter and the tubing that goes to the urine collection bag.

area under the receiver operating
characteristic curve (AUROC) for NGAL is
modest, thus calling into question the ability
to predict intra-operative AKI.14 Other
studies have identified kidney injury
molecule-1 and interleukin-18 as biomarkers
that could potentially be used to detect
AKI.15 In a recent study researchers found
that the AURCO was 0.96 for predicting AKI
based on blood KIM-1 levels. However, the
same study also indicates the blood levels
did not rise until 2 days after surgery in
patients who went on cardiopulmonary
bypass during the surgery.16 As for IL-18, a
study in 103 cardiopulmonary bypass
surgery patients found that there was a
statistical difference between AKI and nonAKI patients. The same study showed that
the sensitivity and specificity of urinary IL-18
was 90.91 and 91.36% at 2 hours after CPB.17
While this is an improvement over current
diagnostic methods it does not enable perioperative intervention of AKI. In addition,
the use of biomarkers is limited by cost and
personnel. These tests require trained
personnel and expensive equipment.

While research has been primarily focused
on traditional urinary or serum biomarkers
other studies have also been done to
determine if urine oxygen concentration can
be used a physical biomarker to detect AKI.
Several studies have shown that tissue
hypoxia is a final common pathway for
multiple forms of AKI.18 Even though the
kidneys receive 20-25% of the cardiac output
and only extract 10-20% of the oxygen
delivered to them they are susceptible to
hypoxia. This is because the medullary
region of the kidney accounts for
approximately 80% of the oxygen extraction
associated with the kidney and due to
complex oxygen conservation and delivery
mechanisms receives oxygen poor blood.19 It
would be ideal to directly measure the tissue
oxygen concentration in the medullary
region of the kidney, however this is not
currently feasible in a clinical setting.
Researchers have proposed measuring urine
oxygen partial pressure (PuO2) as a surrogate
for kidney tissue oxygenation. Leonhardt et
al. were the first to show that there is a linear
relationship between mean medullary tissue
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Figure 2 - A: Results from Leonhardt et al. showing that
PuO2 reflects renal tissue oxygenation. B: Work by
Pannabecker et al. describe the close spatial relationship
between the vasa recta and urinary collecting ducts (Red:
capillaries; Blue: collecting ducts)

oxygen partial pressure and PuO2.20 Their
results are shown in figure 2A. It has since
been shown that the collection of blood
vessels known as the vasa recta run parallel
and lie near the urinary collecting ducts in
the medullary region.21 Pannabecker,
Datnzler and Thomas et al. were the first to
describe this spatial relationship, which is
shown in figure 2B.22 In addition, Evans et al.

demonstrated that it is feasible to measure
urinary oxygen concentration in the bladder
and that those who later develop AKI spend
more time below a designated urinary
oxygen concentration threshold than those
who do not develop AKI.23 Other studies
have shown that urinary oxygen
concentration may be a viable surrogate
measurement
for monitoring
renal
hypoxia.24–26
The goal of this research was to investigate
the use of PuO2 as a potential biomarker to
monitor AKI risk intraoperatively. A novel
device that non-invasively measures urinary
oxygen concentration and urine flow rate
was developed. The device can be placed
between the urinary catheter and tubing
that leads to the urine collection bag.
Identifying a novel biomarker that could be
used intraoperatively could help mitigate or
prevent the development of AKI. It would
also help researchers further study different
therapies and interventions to mitigate or
prevent surgery associated AKI. Preventing
surgery associated AKI would improve
surgical outcomes, save patient’s lives, and
reduce costs associated with hospital and
ICU length of stay.
METHODS
We completed an observational study to
assess the performance of the previously
mentioned device. Following an IRB
approved protocol, 91 patients scheduled
for cardiothoracic surgery, after providing
informed consent, were enrolled at
University of Utah Health Sciences from
February 2018 to November 2019. The
device, which contains a sensor to measure
PuO2, temperature, and urine flow, was
placed at the same time the urinary catheter
was placed. More specifically, the device
measured PuO2 with an optical oxygen
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sensor that uses dynamic luminescence
quenching. In this sensor an indicator dye
immobilized on a small polymer disc is
excited via an optical fiber. The indicator
dye's luminescence is highly specific to
oxygen and both its intensity and its
luminescent decay time are affected by
oxygen partial pressure through the SternVolmer relationship. It is necessary to
correct the measurement for temperature,
as luminescent intensity and decay time are
temperature-dependent.27 All sensors were
sampled at 1 Hz. The device was removed 24
hours after the end of cardiopulmonary
bypass. After removal, each device was
calibrated according to a calibration protocol
using a simulated urine solution at 0% and
13% oxygen partial pressure and high and
low temperature.
Several algorithms were implemented
during data processing. First, in addition to
measuring the flow rate, the flow sensor
flagged certain data points based on error
codes which included air in the sensor, and
flow exceeding the designated flow rate of
the sensor. These and corresponding optical
signal and temperature data points were
ignored as the measurements were deemed
not reliable. As the device does not have a
one-way valve, an algorithm was
implemented to account for backflow of
urine by tracking the volume of negative
urine flow data points and then ensuring the
same volume moves past the sensor when
urine flow becomes positive.
From prior literature it is known that PuO2 is
influenced by the urinary flow rate:28 If the
urine flow rate is below a certain threshold
the measurement is not reliable due to
oxygen exchange between the urine and the
tissue of the urinary tract. As such, one of
the purposes of this study was to assess how
the urine flow threshold below which

oxygen data is ignored affected the
performance of the sensor.
Since data points were designated as invalid,
it is important to exclude patients who do
not meet a certain percent valid data
threshold during the given time period.
Thus, the second purpose of this study was
to assess how the percentage of invalid data
also affected the performance of the device.
Based on these two aims, several data sets
were generated from the raw data. During
processing the urine flow rate threshold was
varied from 0.1 ml/kg/hr to 1.3 ml/kg/hr and
the necessary percentage of valid data was
varied from 10% to 90%. A data set was
generated for each urine flow rate and
percentage of valid data threshold
combination. After generating each data set,
the mean PuO2 was calculated for the period
when the patient was supported by the
cardiopulmonary bypass machine and the
time between the end of cardiopulmonary
bypass and the end of the surgery. A
receiver operator characteristic curve was
then used to assess the performance of the
device and the mean PuO2 measurement
based on the different threshold criteria. In
addition, a Wilcoxon rank sum test was used
to compare the mean PuO2 for the AKI and
non-AKI groups for each time period. In
addition, the patients were separated into
severe and non-severe AKI. The severe AKI
group consisted of patients who met the
diagnostic criteria for stage II or III AKI based
on the KDIGO guidelines. The other patients
were included in the non-severe AKI group.
RESULTS
Preliminary results for the severe AKI group
comparison are presented in figure 3. The
AUC of mean PuO2 for predicting severe AKI
increases slightly as the urine flow threshold
increases at lower valid data percentage
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Figure 3 - The AUC as the urine
flow rate threshold and
necessary percent valid data
threshold vary.

thresholds. The AUC approaches 80% when
the necessary valid data percentage is low,
and the urine flow rate threshold is high.
However, in the same group of patients for
larger valid data percentages there is a
significant drop off in the AUC when the
urine flow threshold reaches a certain point.
The threshold at which the AUC drop off
occurs also corresponds with a decrease in
number of patients who meet the criteria to
be included in the analysis.
DISCUSSION
AKI is a common complication associated
with cardiac surgery. Those who develop AKI
have increased risk of death and hospital
LOS. Current diagnostic criteria are based on
serum creatinine concentrations and urine
output, but they are not renal specific and
can only be used for diagnostic purposes
after the injury has already occurred. Certain
chemical biomarkers such as NGAL, KIM-1
and IL-18 have demonstrated potential to

detect AKI much earlier than the current
methods, but they are expensive, not realtime, and difficult to use. The purpose of this
study was to investigate the performance of
a device which measures urine oxygen
partial pressure outside the body to assess
AKI risk.
This study showed that it is possible to
measure urine oxygen concentration outside
the body and that it could potentially be
used to monitor AKI risk.
As the urine travels through the ureter, into
the bladder and then through the urinary
catheter to our device outside the body
oxygen may diffuse in or out of the urine.
One method to account for the oxygen
exchange is to only include data above a
certain urine flow threshold. The preliminary
data show that increasing this threshold
improves the performance of the device.
However, the data also show that if the flow
threshold is too high the percentage of valid
data decreases which can have a negative
effect on the performance of the device. It is
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important to note that these results are
heavily influenced by the number of patients
included in the analysis. As the criteria
become more strict, fewer patients are
included in the analysis which limit the
statistical power of our observations.
Further research is needed to validate this
observation.
Based on these data we plan to perform
further animal studies to explore the
relationship between PuO2, percentage of
valid data and the ability of the device to
detect AKI. Additionally, the animal studies
will be used to model the oxygen exchange
mathematically which could be applied to
the data to correct for oxygen exchange
thus, including more data in the analysis.
The major limitation of this study is the
population size. This is particularly evident
when the urine flow threshold and necessary
percentage of valid data are high, which
excludes the majority of patients. Another
limitation of this study is the definition of
severe AKI. While the device can predict
severe AKI, these observations cannot be
generalized to more mild forms of AKI.
Lastly, the data analysis was retrospective.
The best method for performing this study
would be to perform a prospective study.

will help improve patient outcomes during
cardiac surgery.
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